These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 2539058)

  • 21. Simultaneous quantification of cyclophosphamide, 4-hydroxycyclophosphamide, N,N',N"-triethylenethiophosphoramide (thiotepa) and N,N',N"-triethylenephosphoramide (tepa) in human plasma by high-performance liquid chromatography coupled with electrospray ionization tandem mass spectrometry.
    de Jonge ME; van Dam SM; Hillebrand MJ; Rosing H; Huitema AD; Rodenhuis S; Beijnen JH
    J Mass Spectrom; 2004 Mar; 39(3):262-71. PubMed ID: 15039933
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Extremely high exposures in an obese patient receiving high-dose cyclophosphamide, thiotepa and carboplatin.
    De Jonge ME; Mathôt RA; Van Dam SM; Beijnen JH; Rodenhuis S
    Cancer Chemother Pharmacol; 2002 Sep; 50(3):251-5. PubMed ID: 12203108
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The additive effect of peripheral blood stem cells, harvested with low-dose cyclophosphamide, to autologous bone marrow reinfusion on hematopoietic reconstitution after ablative chemotherapy in breast cancer patients with localized disease.
    de Graaf H; Mulder NH; Willemse PH; van der Graaf WT; Sleijfer DT; Zijlstra JG; Elias M; Sibinga CT; Vellenga E; de Vries EG
    Anticancer Res; 1995; 15(6B):2851-6. PubMed ID: 8669878
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [High-dose thiotepa chemotherapy in children].
    Izhogin DG; Boiarshinov VK; Dolgonolov IS; Iankelevich MIa; Ptushkina EA; Mentkevich GL
    Vopr Onkol; 2000; 46(4):401-6. PubMed ID: 11147412
    [TBL] [Abstract][Full Text] [Related]  

  • 25. High-dose chemotherapy and autologous stem cell support followed by posttransplantation doxorubicin as initial therapy for metastatic breast cancer.
    deMagalhaes-Silverman M; Bloom E; Lembersky B; Lister J; Pincus S; Rybka W; Voloshin M; Wilson J; Ball E
    Clin Cancer Res; 1997 Feb; 3(2):193-7. PubMed ID: 9815672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Phase I study of high-dose busulfan, melphalan and thiotepa with autologous stem cell support in patients with refractory malignancies.
    Weaver CH; Bensinger WI; Appelbaum FR; Lilleby K; Sandmaier B; Brunvand M; Rowley S; Petersdorf S; Rivkin S; Gooley T
    Bone Marrow Transplant; 1994 Nov; 14(5):813-9. PubMed ID: 7889015
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A feasibility study of multiple cycle therapy with melphalan, thiotepa, and paclitaxel followed by mitoxantrone, thiotepa, and paclitaxel with autologous hematopoietic cell support for metastatic breast cancer.
    Hu WW; Long GD; Stockerl-Goldstein KE; Johnston LJ; Chao NJ; Negrin RS; Blume KG
    Clin Cancer Res; 1999 Nov; 5(11):3411-8. PubMed ID: 10589752
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A delayed side effect of topical thiotepa.
    Hornblass A; Adler RI; Vukcevich WM; Gombos GM
    Ann Ophthalmol; 1974 Nov; 6(11):1155-7. PubMed ID: 4215360
    [No Abstract]   [Full Text] [Related]  

  • 29. High-dose cyclophosphamide, thiotepa and hydroxyurea with autologous hematopoietic stem cell rescue: an effective consolidation chemotherapy regimen for early metastatic breast cancer.
    Vaughan WP; Reed EC; Edwards B; Kessinger A
    Bone Marrow Transplant; 1994 May; 13(5):619-24. PubMed ID: 7914447
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A randomized trial of once vs twice daily administration of intravenous granisetron with dexamethosone in patients receiving high-dose cyclophosphamide, thiotepa and carboplatin.
    Birch R; Weaver CH; Carson K; Buckner CD
    Bone Marrow Transplant; 1998 Oct; 22(7):685-8. PubMed ID: 9818697
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Quality of life in women with breast cancer during the first year after random assignment to adjuvant treatment with marrow-supported high-dose chemotherapy with cyclophosphamide, thiotepa, and carboplatin or tailored therapy with Fluorouracil, epirubicin, and cyclophosphamide: Scandinavian Breast Group Study 9401.
    Brandberg Y; Michelson H; Nilsson B; Bolund C; Erikstein B; Hietanen P; Kaasa S; Nilsson J; Wiklund T; Wilking N; Bergh J;
    J Clin Oncol; 2003 Oct; 21(19):3659-64. PubMed ID: 14512398
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [High-dose chemotherapy for metastatic breast cancer without certain advantages so far].
    Kleeberg UR
    Strahlenther Onkol; 2000 Jul; 176(7):334-5. PubMed ID: 10963001
    [No Abstract]   [Full Text] [Related]  

  • 33. High-dose chemotherapy with peripheral blood stem cell support for stage IIIB inflammatory carcinoma of the breast.
    Schwartzberg L; Weaver C; Lewkow L; McAneny B; Zhen B; Birch R; West W; Tauer K; Buckner C
    Bone Marrow Transplant; 1999 Nov; 24(9):981-7. PubMed ID: 10556957
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Pharmacokinetics of continuous-infusion high-dose thiotepa.
    Henner WD; Shea TC; Furlong EA; Flaherty MD; Eder JP; Elias A; Begg C; Antman K
    Cancer Treat Rep; 1987 Nov; 71(11):1043-7. PubMed ID: 3119200
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [High-dosage chemotherapy and the autologous transplantation of peripheral hematopoietic progenitor cells in breast cancer: the initial results, analysis of toxicity and the necessary support means].
    Sola Rocabert C; Mesía R; Mendoza L; Tabernero JM; Amill B; Maroto P; Bellet M; Ojeda B; Alonso MC; Verger G
    Med Clin (Barc); 1995 Oct; 105(11):407-11. PubMed ID: 7475451
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pegase 03: a prospective randomized phase III trial of FEC with or without high-dose thiotepa, cyclophosphamide and autologous stem cell transplantation in first-line treatment of metastatic breast cancer.
    Biron P; Durand M; Roché H; Delozier T; Battista C; Fargeot P; Spaeth D; Bachelot T; Poiget E; Monnot F; Tanguy ML; Curé H
    Bone Marrow Transplant; 2008 Mar; 41(6):555-62. PubMed ID: 18037940
    [TBL] [Abstract][Full Text] [Related]  

  • 37. High-dose chemotherapy (CTM) for breast cancer.
    Damon LE; Wolf JL; Rugo HS; Gold E; Zander AR; Cassidy M; Cecchi G; Cohen N; Irwin D; Tracy M; Ries CA; Linker CA
    Bone Marrow Transplant; 2000 Aug; 26(3):257-68. PubMed ID: 10967563
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacokinetics of cyclophosphamide and thiotepa in a conventional fractionated high-dose regimen compared with a novel simplified unfractionated regimen.
    Ekhart C; Rodenhuis S; Beijnen JH; Huitema AD
    Ther Drug Monit; 2009 Feb; 31(1):95-103. PubMed ID: 19155964
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiac conduction abnormalities in patients with breast cancer undergoing high-dose chemotherapy and stem cell transplantation.
    Ando M; Yokozawa T; Sawada J; Takaue Y; Togitani K; Kawahigashi N; Narabayashi M; Takeyama K; Tanosaki R; Mineishi S; Kobayashi Y; Watanabe T; Adachi I; Tobinai K
    Bone Marrow Transplant; 2000 Jan; 25(2):185-9. PubMed ID: 10673678
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Altered cyclophosphamide and thiotepa pharmacokinetics in a patient with moderate renal insufficiency.
    Ekhart C; Kerst JM; Rodenhuis S; Beijnen JH; Huitema AD
    Cancer Chemother Pharmacol; 2009 Jan; 63(2):375-9. PubMed ID: 18431571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.